We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Image of Kate Robinson

Kate Robinson profile page

Assistant Editor

Kate graduated from Sheffield Hallam University with a bachelor's degree in biomedical sciences in 2020. During her studies she developed a passion for science communication and after graduating, began a science blog in order to continue writing about trending science news and topics of interest. She joined the editorial team at Technology Networks in 2021. In her role as assistant editor Kate supports the publication’s in-house writers, produces scientific content across all communities and works closely with the managing editor to help coordinate commissioned pieces.

Got a Question for Kate Robinson?

Get in touch using the contact form linked here and we’ll get back to you shortly

Published Content
Total: 78
A person holds three white pills in their hand.

Long COVID Risk Reduced by Common Diabetes Drug

Metformin, a drug commonly used to treat diabetes, can reduce the risk of developing long COVID by over 40%, according to a study.
Illustration of cells seen through a magnifying glass

Cell Therapy

This infographic explores how cell therapies can be made and the potential diseases that they are, and could be, used to treat.
A picture depicting proteins within a cell.
Industry Insight

Increasing Throughput While Protecting Proteome Coverage

At ASMS 2023, Technology Networks spoke with Jim Yano, senior director of product management at Thermo Fisher Scientific, to learn more about the company's novel instrument launches and how they could be applied to personalized medicine.
Floating cancer cells.

Protein Hyperactivation Could Kill Cancer Cells and Bacteria

Technology Networks had the pleasure of speaking with Walid A. Houry, professor of biochemistry at the University of Toronto, to find out about the discovery of compounds that can induce protease hyperactivation to kill cancer cells.
Many different types of oral medication.
Industry Insight

Small Molecule KRAS Inhibitors With Potent Antitumor Activity

In this interview, Technology Networks spoke to Dr. Cameron Pitt to learn more about KRAS as a target for cancer therapeutics, avoiding known resistance mechanisms and the effectiveness of two novel KRAS inhibitors.
Elements of the periodic table.

Where Is ICP-MS Making a Difference?

Inductively coupled plasma-mass spectrometry (ICP-MS) is an analytical technique that can be used across a broad range of applications, a few of which we will explore here.
A fluorescent visual aid seen used during surgery.
Industry Insight

A Non-Invasive Treatment for Difficult-To-Treat Pediatric Brain Cancer

In this interview, Technology Networks spoke to Dr. Stuart Marcus, founder and chief medical officer of SonALAsense, to find out how ALA sonodynamic therapy could be a more effective treatment for diffuse intrinsic pontine glioma and recurrent glioblastoma.
A woman sits on a sofa, holding her knees in an expression of pain.

Drug With Potential To Ease Pain in Osteoarthritis Moves to Clinical Trial

Results from an animal study published in Science Translational Medicine demonstrate that a drug compound can disrupt overactivation of inflammation and manage pain and stiffness in osteoarthritis. The drug will be tested in upcoming Phase I and IIa clinical trials.
Bacteriophages on the surface of a bacterium.

Could Viruses Help in the Fight Against Antibiotic Resistance?

A study published in Nature Chemical Biology suggests that a new bacteriophage screening approach could assist scientists attempting to overcome antibiotic resistance.
A person adding a sweetener to their cup of tea.

Common Sweetener Linked to Increased Clotting and Cardiovascular Risk

According to a study published in Nature Medicine, elevated levels of erythritol in the blood are linked with an increased risk of cardiovascular events, including heart attack and stroke.